Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
MARTEK BIOSCIENCES CORP
| Metric | MARTEK BIOSCIENCES CORP Healthcare |
|---|---|
| Quality Score | 77 / 100 |
| Revenue (latest) | $450M |
| Net income (latest) | $28M |
| Operating margin | 11.3% |
| Net margin | 6.2% |
| Return on equity | 4.2% |
| Return on assets | 3.5% |
| Return on capital (ROCE) | 6.8% |
| Debt / equity | 0.19× |
| Revenue growth (YoY) | 30.4% |
| Altman Z″ (distress) | 7.92 |
| Accruals / assets | −14.8% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.